Abstract
2-Amino-5-(p -hydroxyphenyl)-1,4-pyrazine
and 2-amino-3,5-bis(p -hydroxyphenyl)-1,4-pyrazine
are endowed with excellent antioxidative properties. For a possible
development in medicinal chemistry, the lipophilicity of these lead
compounds has to be increased. Therefore various methods of N -alkylation were systematically explored.
The best results were obtained by quenching aminopyrazinyl anion
with alkyl iodides, and by coupling aldehydes (reductive amination)
in the presence of phenylsilane and tin catalyst. Aminopyrazines
equipped with linear alkyl side-chains of at least six carbons showed
improved radical-scavenging properties in lipidic media.
Key words
pyrazines - alkylations - heterocycles - amines - reductions - antioxidants
References
1
Usami K.
Isobe M.
Tetrahedron
1996,
52:
12061 ; and references cited therein
2a
Cavalier J.-F.
Burton M.
De Tollenaere C.
Dussart F.
Marchand C.
Rees J.-F.
Marchand-Brynaert J.
Synthesis
2001,
5:
768
2b
Cavalier J.-F.
Burton M.
Dussart F.
Marchand C.
Rees J.-F.
Marchand-Brynaert J.
Bioorg. Med. Chem.
2001,
9:
1037
2c
Dubuisson M.
De Wergifosse B.
Kremers P.
Marchand-Brynaert J.
Trouet A.
Rees J.-F.
Free Rad. Res.
2001,
34:
285
2d
Janssens B.
Marchand-Brynaert J.
Rees J.-F.
Free Rad.
Res.
2002,
36:
967
2e Burton, M.; De Tollenaere,
C.; Cavalier, J.-F.; Marchand, C.; Dussart, F.; Marchand-Brynaert,
J.; Rees, J.-F. Free Rad. Res., 2002 , in press.
3 Aryl-substituted N ,N -heterocyclic compounds, method for their
preparation and their use in therapeutics and diagnostics: Marchand-Brynaert,
J.; De Tollenaere, C.; Cavalier, J.-F.; Rees, J.-F. PCT/EP01/05588, 2001
4a
Finkel T.
Holbrook NJ.
Nature
(London)
2000,
408:
239
4b
Cuzzocrea S.
Riley DP.
Caputi AP.
Salvemini D.
Pharmacol.
Rev.
2001,
53:
135
5 For a recent review, see: Salvatore RN.
Yoon CH.
Jung KW.
Tetrahedron
2001,
57:
7785
6a
Krein DM.
Lowary TL.
J. Org. Chem.
2002,
67:
4965 ; and references cited therein
6b
Basu B.
Jha S.
Mridha NK.
Bhuiyan MMH.
Tetrahedron
Lett.
2002,
43:
7967
7a
De Bie DA.
Ostrowicz A.
Geurtsen G.
Van der Plas HC.
Tetrahedron
1988,
44:
2977
7b
McCapra F.
Chang YC.
J. Chem. Soc., Chem.
Commun.
1967,
1011
8
Katritsky AR.
Rachwald S.
Rachwald B.
J.
Chem. Soc., Perkin Trans. 1
1987,
799
9a
Alcaide B.
Plumet J.
Siera MA.
Vicent C.
J.
Org. Chem.
1989,
54:
5763
9b
Devillers I.
De Wergifosse B.
Bruneau M.-P.
Tinant B.
Declercq J.-P.
Touillaux R.
Rees J.-F.
Marchand-Brynaert J.
J. Chem. Soc., Perkin Trans.
2
1999,
1481 ; and references
cited therein
10
Apodaca R.
Xiao W.
Org. Lett.
2001,
3:
1745
11a
Kemal O.
Reese CB.
J.
Chem. Soc., Perkin Trans. 1
1981,
1569
11b
Bernardi P.
Dembech P.
Fabbri G.
Ricci A.
Seconi G.
J.
Org. Chem
1999,
64:
641
12
Terekhova MI.
Petrov ES.
Mikhaleva MA.
Shkurko OP.
Mamaev VP.
Shatenshtein AI.
Zh.
Org. Khim.
1982,
18:
9
13
Robins MJ.
Zhang W.
Tetrahedron Lett.
1992,
33:
1177
14a
Chen Z.-H.
Zhou B.
Yang L.
Wu L.-M.
Liu Z.-L.
J.
Chem. Soc., Perkin Trans. 2
2001,
1835
14b
Liegeois C.
Lermusieau G.
Collin S.
J.
Agric. Food Chem.
2000,
48:
1129
15
Shahidi F.
Wanasundara PKJPD.
Critical
Rev. Food Sci. Nutrition
1992,
32:
67
16a
Brigati G.
Lucarini M.
Mugnaini V.
Pedulli GF.
J. Org.
Chem.
2002,
67:
4828
16b
Wright JS.
Johnson ER.
Dilabio GA.
J. Am. Chem. Soc.
2001,
123:
1173
16c
De Heer MI.
Korth H.-G.
Mulder P.
J. Org. Chem.
1999,
64:
6969
17
Devillers I.
Dive G.
De Tollenaere C.
Falmagne B.
De Wergifosse B.
Rees J.-F.
Marchand-Brynaert J.
Bioorg. Med.
Chem. Lett.
2001,
11:
2305